Abstract
Background: Pancreatic cancer is a difficult malignancy to manage with little improvement in mortality rates over time. Local control remains a challenge. The objective of this review is to discuss patient selection and technical considerations for the safe utilization of stereotactic body radiotherapy (SBRT).
Methods: An online search was completed to review available data. The current literature examining the use and delivery of SBRT for pancreatic cancer was reviewed and summarized. Patient selection criteria, technical considerations, and the implementation of SBRT are described.
Results: Studies thus far have shown promising outcomes for SBRT in terms of potential for conversion from borderline or unresectable to resectable disease as well as the feasibility of delivering SBRT safely.
Conclusion: SBRT represents an emerging treatment option for patients to improve local control through delivery of ablative, high-dose radiation while reducing radiation treatment time as compared to conventionally fractionated chemoradiation. Further studies are needed to explore the full potential and toxicities of SBRT in pancreatic cancer. The importance of technical considerations in this modality cannot be overstated.
Keywords: Surveillance, Epidemiology, and End Results Program (SEER), cancer, Celiac Axis (CA), Superior Mesenteric Artery (SMA), Common Hepatic Artery (CHA), chemoradiation.
Graphical Abstract
Current Cancer Therapy Reviews
Title:The Role of Stereotactic Body Radiation Therapy in Pancreatic Cancer
Volume: 14 Issue: 1
Author(s): Priscilla K. Stumpf and Karyn A. Goodman*
Affiliation:
- Radiation Oncology Department, University of Colorado Cancer Center, 1665 Aurora Court, Room 1032, Aurora, CO, 80045,United States
Keywords: Surveillance, Epidemiology, and End Results Program (SEER), cancer, Celiac Axis (CA), Superior Mesenteric Artery (SMA), Common Hepatic Artery (CHA), chemoradiation.
Abstract: Background: Pancreatic cancer is a difficult malignancy to manage with little improvement in mortality rates over time. Local control remains a challenge. The objective of this review is to discuss patient selection and technical considerations for the safe utilization of stereotactic body radiotherapy (SBRT).
Methods: An online search was completed to review available data. The current literature examining the use and delivery of SBRT for pancreatic cancer was reviewed and summarized. Patient selection criteria, technical considerations, and the implementation of SBRT are described.
Results: Studies thus far have shown promising outcomes for SBRT in terms of potential for conversion from borderline or unresectable to resectable disease as well as the feasibility of delivering SBRT safely.
Conclusion: SBRT represents an emerging treatment option for patients to improve local control through delivery of ablative, high-dose radiation while reducing radiation treatment time as compared to conventionally fractionated chemoradiation. Further studies are needed to explore the full potential and toxicities of SBRT in pancreatic cancer. The importance of technical considerations in this modality cannot be overstated.
Export Options
About this article
Cite this article as:
Stumpf K. Priscilla and Goodman A. Karyn *, The Role of Stereotactic Body Radiation Therapy in Pancreatic Cancer, Current Cancer Therapy Reviews 2018; 14 (1) . https://dx.doi.org/10.2174/1573394714666180119122511
DOI https://dx.doi.org/10.2174/1573394714666180119122511 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Related Books

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Piperidin-4-one: The Potential Pharmacophore
Mini-Reviews in Medicinal Chemistry Interplay Between ACE2 and Angiotensin-(1-7) in the Regulation of Blood Pressure
Current Hypertension Reviews Multicyclic Peptides as Scaffolds for the Development of Tumor Targeting Agents
Current Medicinal Chemistry Chromogranin A in Tumors: More Than a Marker for Diagnosis and Prognosis
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Classifications and Clinical Assessment of Haemorrhoids: The Proctologist’s Corner
Reviews on Recent Clinical Trials Ethanolic Extract of Algerian Propolis and Galangin Decreased Murine Melanoma Tumor Progression in Mice
Anti-Cancer Agents in Medicinal Chemistry Delivery Systems of Opioid Analgesics for Pain Relief: A Review
Current Pharmaceutical Design Editorial (Thematic Issue: Targeting Mammalian Spermatogenesis: A Matter of Support)
Current Molecular Pharmacology Cationic Transfection Lipids in Gene Therapy: Successes, Set-backs, Challenges and Promises
Current Medicinal Chemistry Apoptosis Induction by Ultrasound and Microbubble Mediated Drug Delivery and Gene Therapy
Current Molecular Medicine Treatment Strategy Issues for Chronic HIV-1 Infection in Adults: The Dilemma of Life-long Antiretroviral Treatment
Current Medicinal Chemistry - Anti-Infective Agents MCDCalc: Markov Chain Molecular Descriptors Calculator for Medicinal Chemistry
Current Topics in Medicinal Chemistry A Hypothesis for the Relationship between Depression and Cancer: Role of Ca2+/cAMP Signalling
Anti-Cancer Agents in Medicinal Chemistry Poly(ADP-Ribose) Polymerase Inhibitors: New Pharmacological Functions and Potential Clinical Implications
Current Pharmaceutical Design Solvent-free Methods for Co-crystal Synthesis: A Review
Current Organic Synthesis Smart Biodegradable Nanoparticulate Materials: Poly-lactide-co-glycolide Functionalization with Selected Peptides
Current Nanoscience Recognition of Nucleic Acids by Toll-Like Receptors and Development of Immunomodulatory Drugs
Current Medicinal Chemistry Antiangiogenic Drugs and Tyrosine Kinases
Anti-Cancer Agents in Medicinal Chemistry Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics
Current Drug Metabolism Quantitative Analysis and Pharmacokinetics Study of Integrin Antagonist AP25 in Rat Plasma
Protein & Peptide Letters